Chinese Journal of Integrative Medicine

, Volume 18, Issue 8, pp 571–574

Several considerations in using traditional Chinese patent medicine for cerebral infarction

  • Jia He (何 佳)
  • Yihyun Kwon
  • Chao Li (李 超)
  • Xue-qi Zhang (张学齐)
  • Jian-guo Zhao (赵建国)
Feature Article

DOI: 10.1007/s11655-012-1186-8

Cite this article as:
He, J., Kwon, Y., Li, C. et al. Chin. J. Integr. Med. (2012) 18: 571. doi:10.1007/s11655-012-1186-8

Abstract

Nowadays, a great number of traditional Chinese patent medicine (TCPM) are used more and more widely to treat cerebral infarction in China. When great attention is paid to using TCPM in the real world, several problems can be identified: ignoring the Chinese medicine (CM) therapeutic principle based on syndrome differentiation, a lack of appropriate dosage and usage based on individual patient conditions, and a shortage of evidence from randomized, double-blind, placebo-controlled clinical trials. Furthermore, in terms of evaluation of the TCPM effectiveness, few comprehensive criteria and evaluation methods recognized by the international community exist. This article addresses some opinions regarding the above mentioned problems. Prof. ZHAO Jian-guo

Keywords

cerebral infarctionischemic stroketraditional Chinese patent medicine

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Jia He (何 佳)
    • 1
  • Yihyun Kwon
    • 2
  • Chao Li (李 超)
    • 1
  • Xue-qi Zhang (张学齐)
    • 1
  • Jian-guo Zhao (赵建国)
    • 3
  1. 1.Tianjin University of Traditional Chinese MedicineTianjinChina
  2. 2.National University of Health SciencesLombardUSA
  3. 3.Department of Neurology of Integrated Traditional Chinese and Western MedicineFirst Teaching Hospital of Tianjin University of Traditional Chinese MedicineTianjinChina